Hyperlipidemia Associated with the Use of Protease Inhibitors
Open Access
- 1 July 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (1) , 207-208
- https://doi.org/10.1086/313931
Abstract
Our findings demonstrate the development of significant hyperlipidemia or worsening of preexisting hyperlipidemia with the use of several different PIs. AlthougKeywords
This publication has 7 references indexed in Scilit:
- Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease InhibitorsCirculation, 1999
- Alterations in Serum Levels of Lipids and Lipoproteins with Indinavir Therapy for Human Immunodeficiency Virus‐Infected PatientsClinical Infectious Diseases, 1999
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Vascular complications associated with use of HIV protease inhibitorsThe Lancet, 1998
- Vascular complications associated with use of HIV protease inhibitorsThe Lancet, 1998
- Vascular complications associated with use of HIV protease inhibitorsThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998